• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[改良手动rt-PA脉冲喷雾溶栓治疗下肢动脉闭塞和股腘动脉搭桥术]

[Modified manual rt-PA pulse-spray lysis in occlusions of leg arteries and femoro-popliteal bypasses].

作者信息

Müller-Hülsbeck S, Schwarzenberg H, Link J, Walluscheck K, Brossmann J, Regensburger D, Heller M

机构信息

Klinik für Radiologische Diagnostik, Christian-Albrechts-Universität zu Kiel.

出版信息

Rofo. 1996 Dec;165(6):557-62. doi: 10.1055/s-2007-1015811.

DOI:10.1055/s-2007-1015811
PMID:9026098
Abstract

PURPOSE

The evaluation of local rt-PA pulse-spray-lysis (PSL) by the Katzen infusion wire for treatment of thrombosed leg arteries and bypass grafts.

MATERIAL AND METHOD

21 patients (mean age 64.4 years) with either occluded leg arteries (n = 19) or femorocrural bypass grafts (n = 2) were treated with PSL. Mean length of occlusion was 13.2 +/- 11.6 cm. Time of occlusion ranged from less than one week to 6 months.

RESULTS

In 71.43% (15/21) the occlusions could be successfully recanalized with PSL. The mean rt-PA dose was 10.7 +/- 4.9 mg. Remaining stenoses were handled with PTA (n = 9) and additional stent implantation (n = 3). Additional long-time-lysis with 17.5 mg rt-PA was necessary in two cases, the success rate increased to 81% (17/21). The anlde-brachial-index increased from 0.38 +/- 0.29 to 0.83 +/- 0.32 within 24 hours after intervention. In 4 cases bleeding complications occurred. 5 patients showed reocclusions during 6 months follow-up.

CONCLUSIONS

Local fibrinolysis with rt-PA in PSL technique using the Katzen infusion wire is a feasible and promising treatment of thrombosed leg arteries and grafts. Even careful and dosage-minimized rt-PA application cannot prevent bleeding complications.

摘要

目的

评估使用卡曾灌注导丝进行局部rt-PA脉冲喷雾溶栓(PSL)治疗下肢动脉血栓形成和旁路移植血管的效果。

材料与方法

21例患者(平均年龄64.4岁),其中下肢动脉闭塞患者19例,股腘旁路移植血管患者2例,接受了PSL治疗。平均闭塞长度为13.2±11.6厘米。闭塞时间从不到一周到6个月不等。

结果

71.43%(15/21)的闭塞病变可通过PSL成功再通。rt-PA平均剂量为10.7±4.9毫克。残余狭窄采用经皮腔内血管成形术(PTA,9例)和额外的支架植入术(3例)处理。2例患者需要额外使用17.5毫克rt-PA进行长时间溶栓,成功率提高到81%(17/21)。干预后24小时内,踝臂指数从0.38±0.29提高到0.83±0.32。4例出现出血并发症。5例患者在6个月随访期间出现再闭塞。

结论

使用卡曾灌注导丝的PSL技术中,采用rt-PA进行局部溶栓是治疗下肢动脉和移植血管血栓形成的一种可行且有前景的方法。即使谨慎并尽量减少rt-PA用量,也无法预防出血并发症。

相似文献

1
[Modified manual rt-PA pulse-spray lysis in occlusions of leg arteries and femoro-popliteal bypasses].[改良手动rt-PA脉冲喷雾溶栓治疗下肢动脉闭塞和股腘动脉搭桥术]
Rofo. 1996 Dec;165(6):557-62. doi: 10.1055/s-2007-1015811.
2
[Long-term results after recanalization of acute and subacute thrombotic occlusions of the infra-aortic arteries and bypass-grafts using a rotational thrombectomy device].[使用旋转血栓切除术装置对主动脉下动脉和旁路移植血管急性及亚急性血栓性闭塞进行再通后的长期结果]
Rofo. 2002 Dec;174(12):1559-65. doi: 10.1055/s-2002-35942.
3
[Thrombotic and thromboembolic occlusions of leg arteries and bypasses. Short-term versus long-term lysis].[腿部动脉及旁路的血栓形成与血栓栓塞性闭塞。短期与长期溶栓]
Rofo. 1993 Jun;158(6):536-41. doi: 10.1055/s-2008-1032697.
4
[Simple and effective rt-PA thrombolysis design].[简单有效的重组组织型纤溶酶原激活剂溶栓设计]
Rofo. 1998 Nov;169(5):521-5. doi: 10.1055/s-2007-1015331.
5
[Local thrombolysis in peripheral arterial occlusion].[外周动脉闭塞的局部溶栓治疗]
Herz. 1989 Feb;14(1):12-21.
6
[Factors determining late patency of aortobifemoral bypass graft].[决定主-双股动脉旁路移植术远期通畅率的因素]
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):24-35.
7
Efficacy of thrombolysis in infrainguinal bypass grafts.溶栓治疗在股腘动脉搭桥移植术中的疗效。
Circulation. 1991 Feb;83(2 Suppl):I99-105.
8
[Intraarterial urokinase infusion therapy for arterial occlusive disease of the pelvis and extremities with special reference to short-term high dose infusion].
Nihon Igaku Hoshasen Gakkai Zasshi. 1990 Mar 25;50(3):229-39.
9
[Dacron and polytetrafluoroethylene aorto-bifemoral grafts].[涤纶和聚四氟乙烯主动脉-双股动脉移植血管]
Srp Arh Celok Lek. 1997 Mar-Apr;125(3-4):75-83.
10
Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.
Circulation. 1986 Sep;74(3 Pt 2):I15-20.

引用本文的文献

1
Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion.
Pharmacoeconomics. 2002;20(3):203-13. doi: 10.2165/00019053-200220030-00006.